Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Curaleaf Holdings, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$4.34 |
52 Week High | CA$8.73 |
52 Week Low | CA$3.48 |
Beta | 1.5 |
11 Month Change | -23.99% |
3 Month Change | -43.78% |
1 Year Change | 17.30% |
33 Year Change | -69.86% |
5 Year Change | -51.40% |
Change since IPO | -49.36% |
Recent News & Updates
Curaleaf Holdings, Inc. (TSE:CURA) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless
Aug 13These 4 Measures Indicate That Curaleaf Holdings (TSE:CURA) Is Using Debt Extensively
Jul 19Some Confidence Is Lacking In Curaleaf Holdings, Inc. (TSE:CURA) As Shares Slide 27%
Jun 14Recent updates
Curaleaf Holdings, Inc. (TSE:CURA) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless
Aug 13These 4 Measures Indicate That Curaleaf Holdings (TSE:CURA) Is Using Debt Extensively
Jul 19Some Confidence Is Lacking In Curaleaf Holdings, Inc. (TSE:CURA) As Shares Slide 27%
Jun 14Subdued Growth No Barrier To Curaleaf Holdings, Inc. (TSE:CURA) With Shares Advancing 25%
Jan 19Does Curaleaf Holdings (CSE:CURA) Have A Healthy Balance Sheet?
Dec 11Is Curaleaf Holdings (CSE:CURA) Using Too Much Debt?
Sep 08Curaleaf Holdings (CSE:CURA) Has Debt But No Earnings; Should You Worry?
May 28We Think Curaleaf Holdings (CSE:CURA) Is Taking Some Risk With Its Debt
Sep 05Here's Why Curaleaf Holdings (CSE:CURA) Has A Meaningful Debt Burden
May 20Is Curaleaf Holdings (CSE:CURA) A Risky Investment?
Oct 26Loss-Making Curaleaf Holdings, Inc. (CSE:CURA) Set To Breakeven
Mar 20Is Curaleaf Holdings' (CSE:CURA) Share Price Gain Of 188% Well Earned?
Feb 27Shareholder Returns
CURA | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | -1.4% | 1.7% | 2.2% |
1Y | 17.3% | 40.2% | 12.2% |
Return vs Industry: CURA underperformed the Canadian Pharmaceuticals industry which returned 40.2% over the past year.
Return vs Market: CURA exceeded the Canadian Market which returned 12.2% over the past year.
Price Volatility
CURA volatility | |
---|---|
CURA Average Weekly Movement | 7.5% |
Pharmaceuticals Industry Average Movement | 11.0% |
Market Average Movement | 8.0% |
10% most volatile stocks in CA Market | 16.6% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: CURA's share price has been volatile over the past 3 months.
Volatility Over Time: CURA's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 5,650 | Matt Darin | www.curaleaf.com |
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Curaleaf Holdings, Inc. Fundamentals Summary
CURA fundamental statistics | |
---|---|
Market cap | CA$3.20b |
Earnings (TTM) | -CA$302.93m |
Revenue (TTM) | CA$1.86b |
1.7x
P/S Ratio-10.6x
P/E RatioIs CURA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CURA income statement (TTM) | |
---|---|
Revenue | US$1.36b |
Cost of Revenue | US$732.05m |
Gross Profit | US$627.61m |
Other Expenses | US$848.79m |
Earnings | -US$221.17m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.30 |
Gross Margin | 46.16% |
Net Profit Margin | -16.27% |
Debt/Equity Ratio | 50.9% |
How did CURA perform over the long term?
See historical performance and comparison